At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community.
On Sept. 4, Jay Bhattacharya did something NIH directors rarely do: he appeared before the National Cancer Advisory Board, speaking directly with the NCI advisory board about hot-button policy changes taking place under his leadership at NIH.
The latest notice of a funding opportunity for the Cancer Center Support Grants released by NCI no longer requires submission of a Plan to Enhance Diversity.
Every summer since 2010, ten undergraduate students from diverse backgrounds get the opportunity to explore any curiosities they might have about careers in medicine at Memorial Sloan Kettering Cancer Center.
By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. […]
Allison Dowling knew a career in medicine wasn’t for her. She’d seen firsthand the pain and stress experienced by patients who didn’t have the wherewithal to navigate systemic barriers in health care—problems that often fall outside the jurisdiction of the clinic.
In her final year as a medical student, Francisca Finkel chose an elective rotation that is offered by few med schools: Working with lawyers to resolve non-medical issues that harm patients with cancer.
VOICES of Black Women, the largest population study of Black women in the United States, will be the first of American Cancer Society’s large-scale population studies to be initiated using an AI-driven data management platform—promising to bring observational cancer research out of the age of Excel data files and email sharing.
FDA issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product sponsors in submitting diversity action plans to support certain clinical studies.
So far in 2024, 516 anti-queer bills have been introduced in state legislatures across the country, part of a coordinated effort where bills getting traction in one state are soon parroted by legislators in others.
